Crinetics Pharmaceuticals Growth Metrics (2017-2025) | CRNX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)								-0.33M	-0.05M	0.49M	-0.69M		-0.89M	-1.36M			-1.59M	0.74M
EBITDA Margin Growth (3y) (Quarter)				-0.18M	0.13M		-0.66M	-0.16M	2.28M								-2.54M	-0.13M	-8.11M	0.42M
EBITDA Margin Growth (5y) (Quarter)						-0.98M	-0.91M	-0.57M	-0.04M	-0.42M	-1.50M		-0.82M				-0.21M
EBITDA Margin (QoQ) (Quarter)					0.17M	-0.88M	0.05M	0.33M	0.45M	-0.34M	-1.13M			-0.81M				1.53M	-7.93M	8.86M
EBIT Margin Growth (1y) (Quarter)								-0.38M	-0.07M	0.44M	-0.76M		-0.97M	-1.54M			-1.94M	0.82M
EBIT Margin Growth (3y) (Quarter)				-0.17M	0.17M		-0.65M	-0.20M	2.33M								-2.98M	-0.27M	-9.02M	0.45M
EBIT Margin Growth (5y) (Quarter)						-0.96M	-0.91M	-0.62M	-0.05M	-0.45M	-1.56M		-0.88M				-0.58M
EBIT Margin (QoQ) (Quarter)					0.18M	-0.87M	0.03M	0.28M	0.49M	-0.36M	-1.17M			-0.93M				1.83M	-8.72M	9.75M
EBT Margin Growth (1y) (Quarter)								-0.36M	-0.06M	0.45M	-0.71M		-0.86M	-1.34M			-1.64M	0.73M
EBT Margin Growth (3y) (Quarter)				-0.18M	0.14M		-0.63M	-0.19M	2.25M								-2.57M	-0.16M	-8.18M	0.44M
EBT Margin Growth (5y) (Quarter)						-0.94M	-0.88M	-0.60M	-0.05M	-0.43M	-1.49M		-0.79M				-0.25M
EBT Margin (QoQ) (Quarter)					0.18M	-0.86M	0.05M	0.27M	0.47M	-0.34M	-1.12M			-0.82M				1.55M	-7.98M	8.90M
Enterprise Value Growth (1y) (Quarter)	-33.57%	0.68%	-3.48%	-95.58%	-112.21%	69.38%	-90.54%	89.63%	86.91%	35.54%	61.24%	-1,512.41%	-2,052.27%	-2,045.53%	-504.13%	-142.42%	-44.35%	-38.64%	-26.62%	24.09%
Enterprise Value Growth (3y) (Quarter)		-43.88%	-4.45%	-26.81%	-26.70%	35.29%	-40.90%	33.61%	28.14%	41.91%	8.57%	-48.41%	-81.51%	-61.79%	-64.63%	-59.42%	-59.63%	-167.66%	-43.67%	-209.59%
Enterprise Value Growth (5y) (Quarter)								-19.54%		10.08%	3.39%	-27.79%	-41.79%	-30.24%	-45.64%	-62.80%	-63.06%	-42.28%	-42.36%	-43.17%
Enterprise Value (QoQ) (Quarter)	11.83%	-35.24%	5.12%	-72.87%	4.33%	80.49%	-490.40%	90.60%	-20.84%	3.92%	-255.03%	-291.16%	-61.30%	4.22%	0.03%	-56.96%	3.96%	8.01%	8.70%	5.90%
FCF Margin Growth (1y) (Quarter)								-0.31M	-0.11M	0.18M	-0.46M		-0.68M	-0.78M			-1.63M	0.42M
FCF Margin Growth (3y) (Quarter)				-0.15M	0.15M		-0.57M	-0.11M	1.58M								-2.41M	-0.19M	-6.90M	0.36M
FCF Margin Growth (5y) (Quarter)							-0.80M	-0.47M	-0.07M	-0.39M	-1.19M		-0.63M				-0.73M
FCF Margin (QoQ) (Quarter)					0.17M	-0.60M	-0.20M	0.32M	0.37M	-0.31M	-0.84M			-0.42M				1.63M	-6.91M	7.58M
Interest Coverage Ratio (QoQ) (Quarter)
Net Margin Growth (1y) (Quarter)								-0.36M	-0.06M	0.45M	-0.71M		-0.86M	-1.34M			-1.64M	0.73M
Net Margin Growth (3y) (Quarter)				-0.18M	0.14M		-0.63M	-0.19M	2.25M								-2.57M	-0.16M	-8.18M	0.44M
Net Margin Growth (5y) (Quarter)						-0.94M	-0.88M	-0.60M	-0.05M	-0.43M	-1.49M		-0.79M				-0.25M
Net Margin (QoQ) (Quarter)					0.18M	-0.86M	0.05M	0.27M	0.47M	-0.34M	-1.12M			-0.82M				1.55M	-7.98M	8.90M
Operating Margin Growth (1y) (Quarter)								-0.38M	-0.07M	0.44M	-0.76M		-0.97M	-1.54M			-1.94M	0.82M
Operating Margin Growth (3y) (Quarter)				-0.17M	0.17M		-0.65M	-0.20M	2.33M								-2.98M	-0.27M	-9.02M	0.45M
Operating Margin Growth (5y) (Quarter)						-0.96M	-0.91M	-0.62M	-0.05M	-0.45M	-1.56M		-0.88M				-0.58M
Operating Margin (QoQ) (Quarter)					0.18M	-0.87M	0.03M	0.28M	0.49M	-0.36M	-1.17M			-0.93M				1.83M	-8.72M	9.75M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)			0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)											0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	384.00	-949.00	-0.00M	55.00	0.00M	0.00M	921.00	-849.00	-0.00M	-0.00M	-868.00	0.00M	0.00M	0.00M	0.00M	736.00	477.00	-286.00	-614.00	-0.00M
Return on Capital Employed Growth (3y) (Quarter)			-0.00M	-0.00M	-0.00M	-0.00M	-583.00	-724.00	-643.00	-0.00M	-0.00M	388.00	0.00M	0.00M	0.00M	0.00M	875.00	492.00	-96.00	124.00
Return on Capital Employed Growth (5y) (Quarter)											-0.00M	-0.00M	-0.00M	-411.00	-66.00	0.00M	0.00M	691.00	-668.00	-670.00
Return on Capital Employed (QoQ) (Quarter)	-774.00	-99.00	92.00	836.00	392.00	-173.00	-134.00	-934.00	-0.00M	-0.00M	0.00M	0.00M	458.00	207.00	-395.00	466.00	199.00	-555.00	-723.00	-713.00
Return on Equity Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (3y) (Quarter)	-1.00	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (5y) (Quarter)									-1.00	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Sales Growth (1y) (Quarter)				0.00M				-36.00	-6.00	45.00	-71.00	12.00	-86.00	-134.00	-100.00	-234.00	-164.00	73.00	-647.00	267.00
Return on Sales Growth (3y) (Quarter)				-18.00	14.00	-74.00	-63.00	-19.00	225.00	19.00	7.00	990.00				-258.00	-257.00	-16.00	-818.00	44.00
Return on Sales Growth (5y) (Quarter)						-94.00	-88.00	-60.00	-5.00	-43.00	-149.00	-41.00	-79.00	-164.00	-234.00	-241.00	-25.00	-42.00	-739.00	0.00M
Return on Sales (QoQ) (Quarter)					18.00	-86.00	5.00	27.00	47.00	-34.00	-112.00	111.00	-51.00	-82.00	-77.00	-24.00	19.00	155.00	-798.00	890.00

Research Tools

Crinetics Pharmaceuticals Growth Metrics (2017-2025) | CRNX

Create an account

Sign In

Reset Password